Clinical Trial Update: Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study comparing Bicalutamide 50 mg tablet to Casodex 50 mg tablet in healthy fasting subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Bicalutamide 50 mg Tablet (bicalutamide)
• Casodex 50 mg Tablet (bicalutamide)

Snippet

Sponsor: Kremers Urban Development Company | Conditions: Bioequivalency | Phase 1 | Status: COMPLETED